Advertisement
News
Subscribe to Pharmaceutical Processing News

The Lead

Let's Get The Zohydro Facts Straight

April 11, 2014 | by Associated Press | Comments

Rampant misinformation about Zohydro ER continues to be reported by the media and echoed in Washington D.C. and some states' capitals. These inaccurate and misleading statements are often made without proper context, and are intended to be sensational, to create fear or to generate headlines.

TOPICS:
View Sample

FREE Daily Email Newsletter

Fluid Imaging Technologies Announces Call for Submissions for First Annual Life Sciences & Materials Research Grant

April 15, 2014 4:25 pm | by Fluid Imaging Technologies Inc. | Comments

Laboratory instrumentation manufacturer Fluid Imaging Technologies is pleased to announce the call for submissions for its Life Sciences & Materials Research Grant.                                      

DNA Alternative to Pap Smear Sparks Medical Debate

April 15, 2014 1:41 pm | by MATTHEW PERRONE, AP Health Writer | Comments

A high-tech screening tool for cervical cancer is facing pushback from more than a dozen U.S. patient groups, who warn that the genetic test could displace a simpler, cheaper and more established mainstay of women's health: the Pap smear.  

TOPICS:

Manufacturing Technology Orders Down in February

April 15, 2014 8:49 am | Comments

February U.S. manufacturing technology orders totaled $354.40 million according to AMT - The Association For Manufacturing Technology. This total, as reported by companies participating in the USMTO program, was down 6.6% from January and down 6.2% when compared with the total of $377.82 million reported for February 2013. With a year-to-date total of $733.82 million, 2014 is down 0.6% compared with 2013.

TOPICS:
Advertisement

Prosonix to Market Generic Versions of Mylan’s Inhaled Respiratory Products

April 15, 2014 8:45 am | Comments

PSX1001 and PSX1050, which are the first products to emerge from Prosonix's innovative and proprietary particle engineering platform, are being developed as generic versions to GlaxoSmithKline's pressurized metered dose inhalers (pMDI) Flixotide® and Flovent®, respectively.

TOPICS:

FDA Approves Merck’s Allergy Treatment

April 15, 2014 8:04 am | Comments

Merck has announced that FDA has approved GRASTEK ® (Timothy Grass Pollen Allergen Extract) Tablet for Sublingual Use [2800 Bioequivalent Allergy Units (BAU)]. GRASTEK is an allergen extract indicated as immunotherapy for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis.

TOPICS:

Johnson & Johnson Reports 2014 First-Quarter Results

April 15, 2014 7:56 am | Comments

Johnson & Johnson today announced sales of $18.1 billion for the first quarter of 2014, an increase of 3.5% as compared to the first quarter of 2013. Operational results increased 5.3% and the negative impact of currency was 1.8%.  Domestic sales increased 2.2%.  International sales increased 4.5%, reflecting operational growth of 7.9% and a negative currency impact of 3.4%.

TOPICS:

Medical Pot Measure Could Boost Florida Democrats

April 14, 2014 4:13 pm | by MICHAEL J. MISHAK, Associated Press | Comments

Tied to an unpopular president and his signature health care law, Democrats in the nation's largest swing state see medical marijuana as a potential antidote to political malaise in this year's midterm elections.       

TOPICS:

Report: Glaxo Bribed Doctors in Poland

April 14, 2014 9:25 am | Comments

The BBC reports that pharmaceutical company GlaxoSmithKline is accused of bribing doctors to prescribe medicines in Poland. A "Panorama" show to air Monday evening quotes a former sales representative for the company saying doctors there were paid to prescribe its drugs.

TOPICS:
Advertisement

Sebelius: Health Care Launch 'Terribly Flawed'

April 14, 2014 8:25 am | by PHILIP ELLIOTT, Associated Press | Comments

The Obama administration's timeline for having ready the new health care law's online sign-up system "was just flat out wrong," outgoing Health and Human Services Secretary Kathleen Sebelius said in an interview that aired Sunday.    

TOPICS:

FDA Extends Market Exclusivity of KUVAN Powder for Oral Solution and Tablets

April 14, 2014 8:22 am | Comments

BioMarin Pharmaceutical today announced that the FDA granted KUVAN(R) (sapropterin dihydrochloride) Powder for Oral Solution and Tablets a six-month pediatric exclusivity extension. The FDA action extends KUVAN's market exclusivity to June 2015 and is based on studies submitted in response to a written request by the FDA to investigate the use of KUVAN in pediatric patients from birth to age 6

TOPICS:

BMS Submits NDA for a Fixed-Dose Combination Tablet of Atazanavir Sulfate with Cobicistat for HIV-1

April 14, 2014 8:18 am | Comments

Bristol-Myers Squibb Company announced today the submission of a new drug application (NDA) on April 4, 2014 to the FDA for a fixed-dose combination of atazanavir sulfate, a protease inhibitor marketed as Reyataz®, and cobicistat, an investigational pharmacokinetic enhancer, or boosting agent, that can increase the level of certain HIV-1 medicines in the blood and make them more effective.

TOPICS:

Iraq Scrambles to Fight Polio Surge Amid Conflict

April 14, 2014 8:14 am | by SINAN SALAHEDDIN, Associated Press | Comments

Across parts of Iraq, medical teams in white coats and gloves again roam the streets giving children polio vaccines and marking the walls of their homes, fighting a resurgent virus once more taking advantage of the country's turmoil.   

TOPICS:

Studies: Lab-Grown Nostrils, Vaginas Working Well

April 14, 2014 8:09 am | by MALCOLM RITTER, Associated Press; MARIA CHENG, Associated Press | Comments

Two new studies describe the latest achievements in growing body parts in a lab and transplanting them into people, this time with nostrils and vaginas. Windpipes, bladders, blood vessels and other structures have previously been created in part from a patient's own cells and then implanted.

TOPICS:

Pfizer’s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts

April 14, 2014 8:02 am | Comments

Ian C. Read, chairman and CEO of Pfizer, Inc, was elected chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) at the trade association’s annual meeting. Also elected were Kenneth C. Frazier, chairman, president and CEO of Merck & Co, Inc., as chairman-elect of the PhRMA Board of Directors, and George A. Scangos, Ph.D., CEO of Biogen Idec, as Board treasurer.

TOPICS:

Moberg Pharma Acquires Rights to Topical Formulation for Treatment of Oral Pain

April 14, 2014 7:58 am | Comments

Moberg Pharma AB has entered into a definitive agreement with Oracain II Aps (Denmark) to acquire all assets and global rights to a novel and patent pending oral formulation of the proven substance bupivacaine, for the treatment of pain in the oral cavity.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading